Overview
Obligated since award on contracts active FY2021–FY2026
Click a company to open its profile.
Insight FDA OFFICE OF ACQ GRANT SVCS (75F401) is its largest buyer. See more on the Buyers tab
Prime contract obligationsObligation: money the government has legally committed to a contract. It is not the same as money paid. Example: $6M obligated of a $10M ceiling. Glossary, FY2015–FY2026
No prime awards in FY2026 so far; last obligations in FY2022
Agencies report with a delay; the latest year will rise
Hover over a year to see its value.
Insight Largest year: $310K in FY2015; since FY2021, −$54.5K in FY2022. See more on the Contracts tab
Contracts
1 contracts with an action since FY2021
Click a bar to open its contract.
Insight Stand-alone contracts hold 100% of these contracts' obligations.
Prime contracts with an action in FY2021–FY2026
Find a contract by vehicle, office or end date; sort by money to see the largest.
0 end within 12 months.
Showing 1–1 of 1 contract
| Since award, US$ | |||||
|---|---|---|---|---|---|
| Parent contract (IDVIDV: the record type for any contract that exists to take orders: IDIQs, GWACs, GSA Schedules, BPAs and basic ordering agreements. Glossary) | ObligatedObligation: money the government has legally committed to a contract. It is not the same as money paid. Example: $6M obligated of a $10M ceiling. Glossary | ||||
| HHSF223201510111C | Stand-alone | FDA OFFICE OF ACQ GRANT SVCS (75F401) | $255,460 | Sep 29, 2018 | Ended |
Buyers
Click a bar to open its office page.
Insight Food and Drug Administration placed 100%.
Contracting offices that awarded its prime contracts, FY2021–FY2026
See which offices award its contracts.
1 office awarded only one contract.
Showing 1–1 of 1 office
| Contracts active FY2021–FY2026; obligated since award, US$ | |||||
|---|---|---|---|---|---|
| FDA OFFICE OF ACQ GRANT SVCS (75F401) | Food and Drug Administration | 1 | $255,460 | Sep 1, 2015 | Feb 25, 2022 |
Teaming
Subcontracts it received, by prime order
Whom it works under and on what.
1 subcontracts from 1 prime.
Showing 1–1 of 1 subcontract
| La Jolla Institute For Immunology | 75N93019C00067 | NATIONAL INSTITUTES OF HEALTH NIAID (75N930) | $81,886 | Oct 12, 2023 |
Opportunities
Open opportunities matching its registered industries
Notices in its 1 industry (NAICSNAICS code: a six-digit code for the kind of work a company does. Each contract carries one, and it sets the small-business size limit. Glossary): 622310
No open notice matches these industries today. New notices arrive every day.
Registration and contacts
Registration
- UEI
- NKQ9Y8X3JEH9
- CAGE code
- AK572
- Registration
- Active, expires Nov 4, 2026
- Entity type
- Other
- Location
- Roma
Registered industries (NAICSNAICS code: a six-digit code for the kind of work a company does. Each contract carries one, and it sets the small-business size limit. Glossary)
Registered in 1 industry; primary 622310
- 622310 Specialty (except Psychiatric and Substance Abuse) HospitalsPrimary
Contacts at Istituto Nazionale Per Le Malattie Infettive Lazzaro Spallanzani Irccs
| Contact | Role | As of |
|---|---|---|
| See contactsLocked · 7-day trial or paid plan (name, title and contact details with a 7-day trial or paid plan) | Government business POC · Electronic business POCSAM.gov registrationAs of Nov 4, 2025 | Nov 4, 2025 |
| See contactsLocked · 7-day trial or paid plan (name, title and contact details with a 7-day trial or paid plan) | Alternate government business POC · Alternate electronic business POCSAM.gov registrationAs of Nov 4, 2025 | Nov 4, 2025 |
Correct this listing
Tell us what to correct or add on the Istituto Nazionale Per Le Malattie Infettive Lazzaro Spallanzani Irccs page. We check every request before we change a profile.